Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9830342, 10 pages
https://doi.org/10.1155/2017/9830342
Research Article

Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model

1Liver and Immunology Research Center, Daejeon Oriental Hospital of Daejeon University, 176-9 Daeheung-ro, Jung-gu, Daejeon 34929, Republic of Korea
2TKM-Based Herbal Drug Research Group, Korea Institute of Oriental Medicine, Daejeon 34052, Republic of Korea
3Department of Applied Chemistry, Daejeon University, 62 Daehak-ro, Dong-gu, Daejeon 34520, Republic of Korea

Correspondence should be addressed to Chang-Gue Son; rk.ca.ujd@noskc

Received 30 November 2016; Accepted 9 January 2017; Published 8 February 2017

Academic Editor: Nazli B. Sarikahya

Copyright © 2017 Hyo-Seon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Nunney, C. C. Maley, M. Breen, M. E. Hochberg, and J. D. Schiffman, “Peto’s paradox and the promise of comparative oncology,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, no. 1673, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. C. Murphy, L. C. Harlan, J. L. Lund, C. F. Lynch, and A. M. Geiger, “Patterns of colorectal cancer care in the United States: 1990–2010,” Journal of the National Cancer Institute, vol. 107, no. 10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, “Immunological aspects of cancer chemotherapy,” Nature Reviews Immunology, vol. 8, no. 1, pp. 59–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. T. Halpern and K. R. Yabroff, “Prevalence of outpatient cancer treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS),” Cancer Investigation, vol. 26, no. 6, pp. 647–651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. H. Yun, M. Kwak, S. M. Park et al., “Chemotherapy use and associated factors among cancer patients near the end of life,” Oncology, vol. 72, no. 3-4, pp. 164–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Griffin, P. N. Butow, A. S. Coates et al., “On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993,” Annals of Oncology, vol. 7, no. 2, pp. 189–195, 1996. View at Google Scholar · View at Scopus
  8. K. Jenns, “Importance of nausea,” Cancer Nursing, vol. 17, no. 6, pp. 488–493, 1994. View at Google Scholar · View at Scopus
  9. C. Morran, D. C. Smith, D. A. Anderson, and C. S. McArdle, “Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics,” British Medical Journal, vol. 1, no. 6174, pp. 1323–1324, 1979. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Jordan, C. Sippel, and H.-J. Schmoll, “Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations,” Oncologist, vol. 12, no. 9, pp. 1143–1150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Mahesh, R. V. Perumal, and P. V. Pandi, “Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods,” Pharmazie, vol. 60, no. 2, pp. 83–96, 2005. View at Google Scholar · View at Scopus
  12. S. Goodin and R. Cunningham, “5-HT3-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile,” Oncologist, vol. 7, no. 5, pp. 424–436, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Haus, M. Späth, and L. Färber, “Spectrum of use and tolerability of 5‐HT3 receptor antagonists,” Scandinavian Journal of Rheumatology, vol. 33, supplement 117, pp. 12–18, 2009. View at Publisher · View at Google Scholar
  14. J. H. Kim, Y. C. Shin, and S.-G. Ko, “Integrating traditional medicine into modern inflammatory diseases care: multitargeting by rhus verniciflua stokes,” Mediators of Inflammation, vol. 2014, Article ID 154561, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Shizhen, Compendium of Materia Medica (Bencao Gangmu), Foreign Languages Press, Beijing, China, 2006.
  16. J. E. Moon, J.-H. Shin, O. Kwon, and J. Y. Kim, “A standardized extract of rhus verniciflua stokes protects wistar rats against lipopolysaccharide-induced acute inflammation,” Journal of Medicinal Food, vol. 18, no. 11, pp. 1223–1230, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. P.-S. Oh, S.-J. Lee, and K.-T. Lim, “Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in triton WR-1339-induced hyperlipidemic mice,” Bioscience, Biotechnology and Biochemistry, vol. 70, no. 2, pp. 447–456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K.-C. Choi, W.-T. Chung, J.-K. Kwon et al., “Chemoprevention of a flavonoid fraction from Rhus verniciflua Stokes on aflatoxin B1-induced hepatic damage in mice,” Journal of Applied Toxicology, vol. 31, no. 2, pp. 150–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. R. B. Raghavendran, S. Rekha, J.-W. Shin et al., “Effects of Korean ginseng root extract on cisplatin-induced emesis in a rat-pica model,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 215–221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Kim, H.-P. Kim, C.-H. Jung et al., “Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells,” International Journal of Molecular Medicine, vol. 18, no. 1, pp. 201–208, 2006. View at Google Scholar · View at Scopus
  21. J.-S. Shin, Y. M. Park, J.-H. Choi et al., “Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-κB in RAW 264.7 murine macrophage cells,” International Immunopharmacology, vol. 10, no. 8, pp. 943–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Lebwohl and R. Canetta, “Clinical development of platinum complexes in cancer therapy: an historical perspective and an update,” European Journal of Cancer, vol. 34, no. 10, pp. 1522–1534, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Sassi, B. Striano, and U. A. Merlo, “A reporting system for the assessment of chemotherapy toxicity,” Journal of Oncology Pharmacy Practice, vol. 11, no. 2, pp. 63–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Zhang, B. Wider, H. Shang, X. Li, and E. Ernst, “Quality of herbal medicines: challenges and solutions,” Complementary Therapies in Medicine, vol. 20, no. 1-2, pp. 100–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Nelson, D. Walsh, and F. Sheehan, “Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients,” Supportive Care in Cancer, vol. 10, no. 6, pp. 455–461, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Takeda, S. Hasegawa, M. Morita, and T. Matsunaga, “Pica in rats is analogous to emesis: an animal model in emesis research,” Pharmacology, Biochemistry and Behavior, vol. 45, no. 4, pp. 817–821, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. P. L. R. Andrews and C. C. Horn, “Signals for nausea and emesis: implications for models of upper gastrointestinal diseases,” Autonomic Neuroscience: Basic & Clinical, vol. 125, no. 1-2, pp. 100–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Grunberg, R. R. Deuson, P. Mavros et al., “Incidence of chemotherapy-induced nausea and emesis after modern antiemetics,” Cancer, vol. 100, no. 10, pp. 2261–2268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. L. X. Cubeddu, I. S. Hoffmann, N. T. Fuenmayor, and J. J. Malave, “Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs,” British Journal of Cancer, vol. 66, no. 1, pp. 198–203, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. L. X. Cubeddu, “Serotonin mechanisms in chemotherapy-induced emesis in cancer patients,” Oncology, vol. 53, supplement 1, pp. 18–25, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Gershon, “Review article: serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility,” Alimentary Pharmacology & Therapeutics, vol. 20, supplement 7, pp. 3–14, 2004. View at Google Scholar
  32. A. B. Rogers and J. G. Fox, “Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 286, no. 3, pp. G361–G366, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Sartori, I. Nielsen, A. Maestri, D. Beltrami, L. Trerisani, and P. Pazzi, “Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy: clinical and endoscopic study,” Oncology, vol. 48, no. 5, pp. 356–361, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Montoya, “Managing hematologic toxicities in the oncology patient,” Journal of Infusion Nursing, vol. 30, no. 3, pp. 168–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Okera, S. Chan, U. Dernede et al., “A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings,” British Journal of Cancer, vol. 104, no. 3, pp. 407–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-Y. Son, J.-W. Shin, J.-H. Wang et al., “Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model,” Human and Experimental Toxicology, vol. 30, no. 7, pp. 649–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Kouchi, Y. Maeda, A. Ohuchida, and M. Ohsawa, “Immunotoxic effect of low dose cisplatin in mice,” Journal of Toxicological Sciences, vol. 21, no. 4, pp. 227–233, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-H. Lee, H.-J. Lee, H.-J. Lee et al., “Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice,” Phytomedicine, vol. 16, no. 2-3, pp. 188–197, 2009. View at Publisher · View at Google Scholar · View at Scopus